Koninklijke Philips NV ADR (PHG)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $29.66B
Last updated: Nov 17, 2026 at 4:15 PM ET
Koninklijke Philips NV ADR (PHG) Statistics
Koninklijke Philips NV ADR (PHG) has a market cap of $29.66B. It earned EUR 956.84M on revenue of EUR 17.73B over the last 12 months.
Total Valuation
| Market Cap | $29.66B |
|---|---|
| Latest price (Nov 17, 2026) | $29.89 |
Key Dates
The last ex-dividend date was May 13, 2026.
| Last Earnings Date | Nov 3, 2026 |
|---|---|
| Last Ex-Dividend Date | May 13, 2026 |
| Last Payment Date | Jun 3, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.4x and 2.2x. Its year-end P/S ranged from 0.7x to 2.3x from 2016 to 2025.
| P/S Ratio | 1.4x |
|---|---|
| P/B Ratio | 2.2x |
| P/FCF Ratio | 12.1x |
Enterprise Valuation
Counting debt and cash, the company is valued at 9.9x EBITDA and 14.5x free cash flow.
| EV / EBITDA | 9.9x |
|---|---|
| EV / FCF | 14.5x |
Price Statistics
The stock is up 4.24% over 52 weeks and trades 13.56% above its 50-day average.
| Beta (1Y) | 0.81 |
|---|---|
| 52-Week Change | +4.24% |
| 1-Month Change | +17.20% |
| 3-Month Change | +8.20% |
| 6-Month Change | +14.72% |
| 5-Year Change | -43.03% |
| 10-Year Change | -10.36% |
| Total Return (1Y) | +7.77% |
| Total Return (3Y CAGR) | +13.58% |
| Total Return (5Y CAGR) | -5.27% |
| Return vs SPY (1Y) | -2.85% |
| Max Drawdown (1Y) | -24.79% |
| Max Drawdown (3Y) | -33.81% |
| Sharpe Ratio (1Y) | 0.29 |
| Correlation with SPY (1Y) | 0.38 |
| 50-Day Average | $26.32 |
| 200-Day Average | $26.88 |
| 52-Week Range | $23.62 to $32.19 |
| RSI (14 Days) | 65.2 |
| Average Volume (20 Days) | 1.59M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.33x current liabilities, and total debt is 0.69x shareholder equity.
| Current Ratio | 1.33x |
|---|---|
| Quick Ratio | 0.90x |
| Debt / Equity | 0.69x |
| Debt / EBITDA | 2.55x |
| Interest Coverage | 5.30x |
Returns and Efficiency
Return on invested capital is 7.23% over the last 12 months, against a 5-year average of 0.62%.
| Return on Equity (ROE) | 8.30% |
|---|---|
| Return on Assets (ROA) | 3.43% |
| Return on Invested Capital (ROIC) | 7.23% |
| Return on Capital Employed (ROCE) | 9.58% |
| ROE (5Y Average) | 1.86% |
| ROA (5Y Average) | 0.96% |
| ROIC (5Y Average) | 0.62% |
| Asset Turnover | 0.65x |
| Inventory Turnover | 2.88x |
| Receivables Turnover | 4.94x |
| Cash Conversion Cycle | 120 days |
Taxes
Income tax took 27.84% of pretax income over the last 12 months.
| Income Tax (TTM) | EUR 368.45M |
|---|---|
| Effective Tax Rate | 27.84% |
Scores
PHG has an Altman Z-Score of 2.07, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.07 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of EUR 17.73B over the last 12 months is down 0.29% from the 12 months before.
| Revenue | EUR 17.73B |
|---|---|
| Revenue Growth (YoY) | -0.29% |
| Gross Profit | EUR 8.23B |
| Operating Income | EUR 1.86B |
| Pretax Income | EUR 1.32B |
| Net Income | EUR 956.84M |
| EBITDA | EUR 3.14B |
| EBIT | EUR 1.96B |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 41.33% of the EUR 28.50B in total assets.
| Working Capital | EUR 2.64B |
|---|---|
| Shareholder Equity | EUR 11.78B |
| Tangible Book Value | EUR -710.83M |
| Total Assets | EUR 28.50B |
| Total Liabilities | EUR 16.70B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After EUR 388.78M of capital spending, operating cash flow left EUR 2.11B of free cash flow.
| Operating Cash Flow | EUR 2.50B |
|---|---|
| Capital Expenditures | EUR 388.78M |
| Free Cash Flow | EUR 2.11B |
| Depreciation and Amortization | EUR 1.18B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 10.50%, against a 5-year average of 0.99%.
| Gross Margin | 46.43% |
|---|---|
| Operating Margin | 10.50% |
| Pretax Margin | 7.46% |
| Net Margin | 5.40% |
| EBITDA Margin | 17.69% |
| EBIT Margin | 11.05% |
| FCF Margin | 11.92% |
| Gross Margin (5Y Average) | 42.29% |
| Operating Margin (5Y Average) | 0.99% |
| Net Margin (5Y Average) | 1.78% |
Growth
Revenue grew 0.01% a year over 3 years.
| Revenue Growth (3Y CAGR) | +0.01% |
|---|---|
| Revenue Growth (5Y CAGR) | +0.59% |
| FCF Growth (5Y CAGR) | -13.41% |
Dividends and Yields
PHG pays out 90.56% of earnings as dividends.
| Dividend Per Share (Annual) | $1.01 |
|---|---|
| Dividend Yield | 3.39% |
| Payment Schedule | Annual |
| Payout Ratio | 90.56% |
| FCF Yield | 8.29% |
Stock Splits
The last split was a 4-for-1 forward split on Apr 18, 2000.
| Last Split Date | Apr 18, 2000 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 4:1 |
Peer Position
Against 12 similar companies, PHG has the lowest P/S and the highest dividend yield.
P/S RatioPeer median 3.3x
ROICPeer median 9.82%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.87%
Dividend YieldPeer median 0.10%
| P/S Ratio | 1.4x vs 3.3x median |
|---|---|
| ROIC | 7.23% vs 9.82% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -0.29% vs +8.87% median |
| Dividend Yield | 3.39% vs 0.10% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PHG
What is PHG's market cap?
Koninklijke Philips NV ADR has a market cap of $29.66B.
How many shares of PHG are outstanding?
Koninklijke Philips NV ADR has 989.90M shares outstanding. The count is up 2.70% from a year earlier.
Does PHG pay a dividend?
Yes. Koninklijke Philips NV ADR pays $1.01 a share a year, a dividend yield of 3.39%.
PHG pages: Overview, Dividends, Charting, Financials, Statistics, Valuation, Competitors, Government Contracts